Filter Search for grants
Call Navigation
Call key data
Call for proposals to support the development of innovative medical countermeasures for chemical, biological, radiological and nuclear threats (HERA) - Medicinal products
Funding Program
EU4Health programme 2021-2027
Call number
EU4H-2025-HERA-PJ-1-a
deadlines
Opening
04.09.2025
Deadline
04.12.2025 17:00
Funding rate
60%
Call budget
€ 18,000,000.00
Estimated EU contribution per project
Between € 5,500,000 and € 9,000,000
Link to the call
Link to the submission
Call content
short description
The objective is to improve the Union’s readiness to respond to intentional health threats, including cross-border ones, by supporting the development of medical countermeasures to biological, chemical and radio-nuclear agents for which there currently are no or only limited treatment options.
Call objectives
This action will focus on supporting advanced research on threat-agnostic medical countermeasures against CBRN agents and platform approaches to treat injuries from CBRN agents.
Expected effects and impacts
This action is expected to increase the preparedness of the Union to respond to CBRN threats and improve the availability of medical countermeasures against these threats. It should advance one or more medical countermeasures against CBRN threats along the steps towards regulatory approval and market readiness. In particular:
- For countermeasures against biological threats, this includes vaccines, therapeutics (such as antivirals, small molecules, antimicrobials, monoclonals and polyclonals).
- For countermeasures against chemical agents, this includes antidotes, supportive treatments, and innovation in application devices or techniques.
- For countermeasures against radio-nuclear agents, treatments against acute radiation syndrome, against bone marrow suppression, and decorporation agents after exposure to radioactive substances.
Expected results
The range of activities include an end-to-end approach to bridge the gap between advanced research, innovation, market access and deployment by supporting:
- Advanced research and development (‘R&D’) to support the development of medical countermeasures;
- Involving end users and security practitioners to bring the research products closer to market readiness; and
- Support research into market readiness or facilitate tech and entrepreneurial skills development.
Eligibility Criteria
Regions / countries for funding
Moldova (Moldova), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Iceland (Ísland), Montenegro (Црна Гора), Norway (Norge), Ukraine (Україна)
eligible entities
Education and training institution, International organization, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
No
Project Partnership
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs))
- listed EEA countries and countries associated to the EU4Health Programme (list of participating countries)
other eligibility criteria
Specific cases
- Natural persons are NOT eligible (with the exception of self-employed persons, i.e. sole traders, where the company does not have legal personality separate from that of the natural person).
- International organisations are eligible. The rules on eligible countries do not apply to them.
- Entities which do not have legal personality under their national law may exceptionally participate, provided that their representatives have the capacity to undertake legal obligations on their behalf, and offer guarantees for the protection of the EU financial interests equivalent to that offered by legal persons
- EU bodies (with the exception of the European Commission Joint Research Centre) can NOT be part of the consortium.
- Associations and interest groupings - entities composed of members may participate as ‘sole beneficiaries’ or ‘beneficiaries without legal personality’. Please note that if the action will be implemented by the members, they should also participate (either as beneficiaries or as affiliated entities, otherwise their costs will NOT be eligible).
- European Reference Networks (ERNs) — These cover networks between healthcare providers and centres of expertise in the Member States to reinforce healthcare cooperation, in particular in the area of rare diseases, in line with the objectives set out in Article 12 of Directive 2011/24.
- Countries currently negotiating association agreements — Beneficiaries from countries with ongoing negotiations for participation in the programme (see list of participating countries) may participate in the call and can sign grants if the negotiations are concluded before grant signature and if the association covers the call (i.e. is retroactive and covers both the part of the programme and the year when the call was launched).
- EU restrictive measures — Special rules apply for entities subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU). Such entities are not eligible to participate in any capacity, including as beneficiaries, affiliated entities, associated partners, subcontractors or recipients of financial support to third parties (if any).
- EU conditionality measures — Special rules apply for entities subject to measures adopted on the basis of EU Regulation 2020/209214. Such entities are not eligible to participate in any funded role (beneficiaries, affiliated entities, subcontractors, recipients of financial support to third parties, etc). Currently such measures are in place for Hungarian public interest trusts established under the Hungarian Act IX of 2021 or any entity they maintain (see Council Implementing Decision (EU) 2022/2506, as of 16 December 2022)
Additional information
Topics
Relevance for EU Macro-Region
EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region
UN Sustainable Development Goals (UN-SDGs)
project duration
between 24 and 48 months
Additional Information
Proposals must be submitted electronically via the Funding & Tenders Portal Electronic Submission System. Paper submissions are NOT possible.
Proposals must be complete and contain all the requested information and all required annexes and supporting documents:
- Application Form Part A — contains administrative information about the participants (future coordinator, beneficiaries and affiliated entities) and the summarised budget for the project (to be filled in directly online)
- Application Form Part B — contains the technical description of the project (template to be downloaded from the Portal Submission System, completed, assembled and re-uploaded)
- mandatory annexes and supporting documents (templates to be downloaded from the Portal Submission System, completed, assembled and re-uploaded):
- detailed budget table/calculator
- CVs (standard) of core project team
- list of previous projects (key projects for the last 4 years) (template available in Part B)
- Other annexes:
- A Security Issues Table with three sub-tables on 1) EU classified information (EUCI) and participation of non-EU countries; 2) Misuse; and 3) Other security issues (see the guide How to handle security-sensitive projects for guidance and models). Where appropriate, this annex should include a proposed plan to mitigate potential misuse risks, including proposed oversight mechanisms and compliance with relevant security frameworks. For additional information, see the Guidance note on potential misuse of research. Please note that proposals must NOT contain classified information.
- List of previously submitted patents.
- Previous development activities of proposed solution(s) and relevant technical or scientific (preliminary) data that supports the feasibility of the solution(s).
- (Self-)Declaration of GMP (Good Manufacturing Practice) compliance by applicants and/or subcontractors.
Proposals are limited to maximum 70 pages (Part B).
Financial support to third parties is not allowed.
Call documents
Call Document EU4H-2025-HERA-PJCall Document EU4H-2025-HERA-PJ(1104kB)
Contact
HaDEA-HP-CALLS@ec.europa.eu
Website
European Health and Digital Executive Agency - HaDEA - National Contact Points
Website
To see more information about this call, you can register for free here
or log in with an existing account.
Log in
Register now